J&J Dumps Wrist Device IP To Clear Way For $21B Synthes Buy

Law360, New York (June 11, 2012, 6:46 PM EDT) -- Johnson & Johnson on Monday agreed to sell its patented system used to treat wrist fractures to Biomet Inc. in order to gain U.S. regulatory approval for its planned $21.3 billion purchase of Swiss orthopedic device maker Synthes Inc.

The U.S. Federal Trade Commission signed off on the $21.3 billion deal after J&J said it would sell off the rights to its system for treating distal radius wrist fractures, known as its DVR business, in an effort to relieve the watchdog's concerns over the anti-competitive effects...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.